Images List Premium Download Classic

Vascular Diseases

Vascular Diseases-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Use of ginseng extract, ginsenoside and ginsenoside derivative in the preparation of medicine or health ...
May 17, 2018 - N°20180133273

The invention discloses new application of a ginseng extract, ginsenoside and a ginsenoside derivative in the preparation of a medicine for treating hcmv infection related diseases. The related diseases comprise hcmv infection caused in the process of treating cardiovascular and cerebrovascular diseases, organ transplantation, perinatal periods, tumors, burn, aids and other diseases of patients. Tests prove that the ginseng extract, ...
A method for predicting the risk of incidence of chronic kidney diseases
Sphingotec Gmbh
May 10, 2018 - N°20180128838

The present invention relates to means and methods suitable for risk prediction of chronic kidney disease (ckd) using pro-enkephalin or fragments thereof as biomarker. The risk prediction methods of the invention are intended for healthy subjects and for subjects suffering from diseases such as hypertension, cardiovascular diseases and events, diabetes, metabolic syndrome, obesity, or autoimmune diseases. Subject matter of the ...
Method for the prognosis and/or diagnosis of an illness based on a sample of ...
Lipozyt Marker Ug
May 10, 2018 - N°20180127826

The invention relates to a method for the prognosis of adiposity and the prognosis and/or diagnosis of a disease selected from the group consisting of diabetes, cardiovascular diseases and metabolic syndrome.
Vascular Diseases Patent Pack
Download 120+ patent application PDFs
Vascular Diseases Patent Applications
Download 120+ Vascular Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 120+ full patent PDF documents of Vascular Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
May 10, 2018 - N°20180127425

Wherein r1a, r1b, r2, r4, r5, r6, r7, r8, w, x, y, z, cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (npp2 or enpp2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving ...
Benzothiazole or benzoxazole compounds as sumo activators
Icahn School Of Medicine At Mount Sinai
May 10, 2018 - N°20180127407

Provided are sumo activators, which can enhance sumoylation of serca2a, which are useful in the treatment of heart failure, cardiovascular diseases, cancer, neurodegenerative disorders, viral infection, bacterial infection, liver disease, inflammation, and other diseases.
Therapeutic peptides for cerebrovascular diseases
Prime Bio-drug Development Limited
May 10, 2018 - N°20180125923

The present invention provides a method for treating or ameliorating cerebrovascular diseases in a subject by using peptides isolated from extracts from rabbit skin inflamed by vaccinia virus. The present invention also provides a peptide comprising an amino acid sequence having at least 70% identity to seq id no: 1, or variants, mutants, derivatives, or fragments thereof.
Vascular Diseases Patent Pack
Download 120+ patent application PDFs
Vascular Diseases Patent Applications
Download 120+ Vascular Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 120+ full patent PDF documents of Vascular Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Modulators of farnesoid x receptor and methods for the use thereof
Xiamen University
May 03, 2018 - N°20180116993

Compounds, compositions and methods are provided for treating the fxr-mediated disease or process in a mammal, comprising administering to the mammal a therapeutically effective amount of a compound claimed, wherein the fxr-mediated disease or condition linked to chronic liver diseases such as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis; gastrointestinal diseases; cardiovascular diseases; metabolic diseases such as diabetes and obesity; ...
Methods for inducing cell division of postmitotic cells
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Glads
April 26, 2018 - N°20180112282

The present disclosure provides methods for inducing cell cycle reentry of postmitotic cell. The present disclosure further provides cells and compositions for treating diseases, such as cardiovascular diseases, neural disorders, hearing loss, and diabetes.
Chlorin e6 derivative and pharmaceutically acceptable salt thereof and process for preparing and use of ...
April 26, 2018 - N°20180111945

Chlorin e6 derivatives and pharmaceutically acceptable salt thereof, as well as preparation and use thereof, which belongs to the medicine field. The chlorin e6 ether amino acid derivative has general structural formula i and optical isomers thereof. The preparation process has etherification of 3-vinyl in chlorin e6, a peptide is produced from 15-carboxylethyl and amino acid. The chlorin e6 ether ...
Novel cyclosporin derivatives and uses thereof
April 19, 2018 - N°20180105558

Or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.
Compounds for the prevention and treatment of cardiovascular diseases
Resverlogix Corp.
April 19, 2018 - N°20180104245

The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein a-i (apoa-i), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of ...
Volant Holdings Gmbh
April 12, 2018 - N°20180099001

The present invention is directed to a system characterization of nash that combines modeling and biomarkers, enabling pharmaceutical compositions and methods of treatment that relate to the inhibition, resolution and/or prevention of non alcoholic fatty liver disease (nafld) and non alcoholic steatohepatitis (nash). Said conditions are liver related complications among the array of manifestations of metabolic syndromes, including type 2 ...
Substituted n-(lh-indazol-4-yl)imidazo[l,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine ...
March 29, 2018 - N°20180086758

And pharmaceutically acceptable salts thereof in which r1, r2, r3, r4, r5 and r6 have the meanings given in the specification, are inhibitors of cfms and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.
Vascular Diseases Patent Pack
Download 120+ patent application PDFs
Vascular Diseases Patent Applications
Download 120+ Vascular Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 120+ full patent PDF documents of Vascular Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Human coronary passport
March 15, 2018 - N°20180075206

The technical result is accomplished by virtue of the fact that the present invention represents a universal automated system which is able to identify the risk of developing cardiovascular diseases, plan a treatment, and recommend lifestyle changes, for all people, particularly those not previously assigned to risk groups, with the purpose of warning and preventing cvd (cardiovascular diseases). For the ...
Treatment of diabetes using agonists of the mas-related gpcr d
March 15, 2018 - N°20180074053

Methods of identifying agonists of mrgd for treating prediabetes, type-2 diabetes and cardiovascular diseases or disorders. Methods of treating prediabetes, type-2 diabetes and cardiovascular diseases or disorders comprising administering to a subject an agonist of mrgd.
Tricyclic analogues, preparation method and uses thereof
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
March 08, 2018 - N°20180064696

The present invention relates to a series of analogues of natural product pyripyropene a represented by general formula i and a preparation method and use thereof. More particularly, the present invention relates to analogues of the natural product pyripyropene a, a preparation method and use thereof as the acyl-coa:cholesterol acyltransferase 2 (acat2) inhibitors for the treatment of cardiovascular diseases such ...
Saxatilin-fc fusion protein and use thereof
Industry-academic Cooperation Foundation, Yonsei University
March 01, 2018 - N°20180057549

The present invention relates to a saxatilin derivative having an increased half life and a use thereof. The saxatilin derivative of the present invention has thrombolytic ability similar to that of saxatilin, which is the mother protein, a remarkably increased protein half life, and efficiently dissolves, for long period of time, blood clots already formed in blood vessels of an ...
Bioengineered allogeneic blood vessel
Novahep Ab
March 01, 2018 - N°20180055973

The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or ...
Curevac Ag
March 01, 2018 - N°20180055952

The present application describes a coding nucleic acid sequence, particularly a messenger rna (mrna), comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal and the use thereof for increasing the expression of an encoded protein. It also discloses its use for the preparation of a pharmaceutical composition, especially a vaccine e. G. For ...
Treatment of heart disease
Aal Scientifics, Inc.
March 01, 2018 - N°20180055889

Disclosed herein are methods, compositions and kits for treating cardiac stem cells to be administered to a subject in need thereof, e. G., with a damaged myocardium. The methods, composition and kits of the invention can be used to treat cardiovascular diseases such as heart failure, myocardial infarction and an age-related cardiomyopathy.
19-nor neuroactive steroids and methods of use thereof
Sage Therapeutics, Inc.
February 22, 2018 - N°20180051052

Provided herein are 3,3-disubstituted 19-nor-steroidal compounds according to formula (1): and pharmaceutical compositions thereof. Such compounds are contemplated useful for the prevention and treatment of a variety of cns-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance ...
Loading